oxazolidin-2-one has been researched along with Corneal Ulcer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, S; Tu, EY | 1 |
| Erdurmus, M; Hakyemez, IN; Kucukbayrak, A; Mengeloglu, FZ; Ozyalvacli, G; Simavli, H; Tas, T | 1 |
2 other study(ies) available for oxazolidin-2-one and Corneal Ulcer
| Article | Year |
|---|---|
Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis.
Topics: Acetamides; Administration, Topical; Anti-Infective Agents; Corneal Ulcer; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Ophthalmic Solutions; Oxazolidinones; Retrospective Studies; Staphylococcus; Streptococcus mitis; Vancomycin Resistance | 2013 |
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Topics: Acetamides; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Colony Count, Microbial; Colony-Forming Units Assay; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Ophthalmic Solutions; Oxazolidinones; Rabbits; Staphylococcal Infections; Vancomycin | 2013 |